Relating chemical and biological diversity space: A tunable system for efficient gene transfection

ChemBioChem

Volumn 9, Issue 12, 2008, Pages 1960-1967

  Van Vliet, Liisa D ^a   Chapman, Michael R ^a   Avenier, Frédéric ^a   Kitson, Chris Z ^b   Hollfelder, Florian ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Chemical space; Combinatorial chemistry; Gene technology; Nonviral gene delivery; Polyethyleneimine

Indexed keywords

LIPOFECTAMINE; POLYETHYLENEIMINE;

ANALYTICAL EQUIPMENT; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BIOLOGICAL ACTIVITY; CELL TYPE; CHEMICAL ANALYSIS; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DERIVATIZATION; DNA BINDING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; DNA; POLYMERS; TRANSFECTION;

EID: 54349109353     PISSN: 14394227     EISSN: 14397633     Source Type: Journal    
DOI: 10.1002/cbic.200800003     Document Type: Article

References (85)

1. L. Cao, Z. C. Zheng, Y. C. Zhao, Z. H. Jiang, Z. G. Liu, S. D. Chen, C. F. Zhou, X. Y. Liu, Hum. Gene Ther. 1995, 6, 1497-1501.
2. I. M. Verma, M. D. Weitzman, Annu. Rev. Biochem. 2005, 74, 711-738.
3. a) T. Niidome, L. Huang, Gene Ther. 2002, 9, 1647-1652;
4. b) J. A. Wolff, Nat. Biotechnol. 2002, 20, 768-769.
5. M. E. Davis, Curr. Opin. Biotechnol. 2002, 13, 128-131.
6. M. Thomas, A. M. Klibanov, Appl. Microbiol. Biotechnol. 2003, 62, 27-34.
7. a) W. H. Sun, J. K. Burkholder, J. Sun, J. Culp, J. Turner, X. G. Lu, T D. Pugh, W. B. Ershler, N. S. Yang, Proc. Natl. Acad Sci. USA 1995, 92, 2889-2893;
8. b) H. Herweijer, J. A. Wolff, Gene Ther. 2007, 14, 99-107.
9. J. Dobson, Gene Ther. 2006, 13, 283-287.
10. a) C. Chittimalla, L. Zammut-Italiano, G. Zuber, J. P. Behr, J. Am. Chem. Soc. 2005, 127, 11436-11441;
11. b) K. Na, S. Kim, K. Park, K. Kim, D. G. Woo, I. C. Kwon, H. M. Chung, K. H. Park, J. Am. Chem. Soc. 2007, 129, 5788-5789;
12. c) C. R. Safinya, Curr. Opin. Struct. Biol. 2001, 11, 440-448.
13. a) G. T. Zugates, D. G. Anderson, S. R. Little, I. E. Lawhorn, R. Langer, J. Am. Chem. Soc. 2006, 128, 12726-12734;
14. b) M. D. Brown, A. G. Schatzlein, I. F. Uchegbu, Int. J. Pharm. 2001, 229, 1-21;
15. c) H. Eliyahu, Y. Barenholz, A. J. Domb, Molecules 2005, 10, 34-64;
16. d) T. Merdan, J. Kopecek, T. Kissel, Adv. Drug Delivery Rev. 2002, 54, 715-758;
17. e) D. W. Pack, A. S. Hoffman, S. Pun, P. S. Stayton, Nat. Rev. Drug Discovery 2005, 4, 581-593;
18. f) T. Segura, L. D. Shea, Ann. Rev. Mater. Res. 2001, 31, 25-46;
19. g) J. A. Wolff, D. B. Rozema, Mol. Ther. 2007, 16, 8-15.
20. A. J. Kirby, P. Camilleri, J. B. Engberts, M. C. Feiters, R. J. Nolte, O. Soderman, M. Bergsma, P. C. Bell, M. L. Fielden, C. L. Garcia Rodriguez, P. Guedat, A. Kremer, C. McGregor, C. Perrin, G. Ronsin, M. C. van Eijk, Angew. Chem. 2003, 715, 1486-1496; Angew Chem. Int. Ed. 2003, 42, 1448-1457.
21. C. R. Safinya, K. Ewert, A. Ahmad, H. M. Evans, U. Raviv, D. J. Needleman, A. J. Lin, N. L. Slack, C. George, C. E. Samuel, Philos. Trans. R. Soc. London Ser. A 2006, 364, 2573-2596.
22. I. van der Woude, A. Wagenaar, A. A. Meekel, M. B. ter Beest, M. H. Ruiters, J. B. Engberts, D. Hoekstra, Proc. Natl. Acad. Sci. USA 1997, 94, 1160-1165.
23. C. W. Pouton, P. Lucas, B. J. Thomas, A. N. Uduehi, D. A. Milroy, S. H. Moss, J. Controlled Release 1998, 53, 289-299.
24. a) J. Haensler, F. C. Szoka, Jr., Bioconjug. Chem. 1993, 4, 372-379;
25. b) D. R. Radu, C. Y. Lai, K. Jeftinija, E. W. Rowe, S. Jeftinija, V. S. Lin, J. Am. Chem. Soc. 2004, 126, 13216-13217.
26. M. Krämer, J. F. Stumbé. Grimm, B. Kaufmann, U. Krüger, M. Weber, R. Haag, ChemBioChem 2004, 5, 1081-1087.
27. O. Boussif, F. Lezoualch, M. A. Zanta, M. D. Mergny, D. Scherman, B. Demeneix, J. P. Behr, Proc. Natl. Acad. Sci. USA 1995, 92, 7297-7301.
28. a) J.-S. Remy, B. Abdallah, M. A. Zanta, O. Boussif, J.-P. Behr, B. Demeneix, Adv. Drug Delivery Rev. 1998, 30, 85-95;
29. b) M. Neu, D. Fischer, T. Kissel, J. Gene Med. 2005, 7, 992-1009.
30. A. D. Miller, Angew. Chem. 1998, 110, 1862-1880; Angew. Chem. Int. Ed. 1998, 37, 1768-1785.
31. K. Ewert, H. M. Evans, A. Ahmad, N. L. Slack, A. J. Lin, A. Martin-Herranz, C. R. Safinya, Adv. Genet. 2005, 53PA, 119-155.
32. I. S. Zuhorn, J. B. Engberts, D. Hoekstra, Eur. Biophys. J. 2007, 36, 349-362.
33. B. Ma, S. Zhang, H. Jiang, B. Zhao, H. Lv, J. Control. Release 2007, 123, 184-194.
34. C. McGregor, Ph.D. thesis, University of Cambridge, 2001.
35. M. Scarzello, J. Smisterova, A. Wagenaar, M. C. Stuart, D. Hoekstra, J. B. Engberts, R. Hulst, J. Am. Chem. Soc. 2005, 127, 10420-10429.
36. S. R. Popielarski, S. Mishra, M. E. Davis, Bioconjugate Chem. 2003, 14, 672-678.
37. K. Lenssen, P. Jantscheff, G. von Kiedrowski, U. Massing, ChemBioChem 2002, 3, 852-858.
38. D. G. Anderson, W. Peng, A. Akinc, N. Hossain, A. Kohn, R. Padera, R. Langer, J. A. Sawicki, Proc. Natl. Acad. Sci. USA 2004, 101, 16028-16033.
39. a) D. M. Lynn, D. G. Anderson, D. Putnam, R. Langer, J. Am. Chem. Soc. 2001, 123, 8155-8156;
40. b) D. G. Anderson, D. M. Lynn, R. Langer, Angew. Chem. 2003, 115, 3261-3266; Angew. Chem. Int. Ed. 2003, 42, 3153-3158.
41. A. Akinc, D. M. Lynn, D. G. Anderson, R. Langer, J. Am. Chem. Soc. 2003, 125, 5316-5323.
42. a) D. G. Anderson, A. Akinc, N. Hossain, R. Langer, Mol. Ther. 2005, 11, 426-434;
43. b) A. N. Zelikin, D. Putnam, P. Shastri, R. Langer, V. A. Izumrudov, Bioconjugate Chem. 2002, 13, 548-553.
44. J. J. Green, J. Shi, E. Chiu, E. S. Leshchiner, R. Langer, D. G. Anderson, Bioconjugate Chem. 2006, 17, 1162-1169.
45. G. T. Zugates, W. Peng, A. Zumbuehl, S. Jhunjhunwala, Y. H. Huang, R. Langer, J. A. Sawicki, D. G. Anderson, Mol. Ther. 2007, 15, 1306-1312.
46. a) M. Mammen, S. K. Choi, G. M. Whitesides, Angew. Chem. 1998, 110, 2908-2953; Angew. Chem. Int. Ed. 1998, 37, 2754-2794;
47. b) R. Haag, F. Kratz, Angew. Chem. 2006, 118, 1218-1237; Angew. Chem. Int. Ed. 2006, 45, 1198-1215.
48. M. Thomas, J. J. Lu, Q. Ge, C. Zhang, J. Chen, A. M. Klibanov, Proc. Natl. Acad. Sci. USA 2005, 102, 5679-5684.
49. N. P. Gabrielson, D. W. Pack, Biomacromolecules 2006, 7, 2427-2435.
50. M. Thomas, A. M. Klibanov, Proc. Natl. Acad. Sci. USA 2002, 99, 14640-14645.
51. M. Thomas, Q. Ge, J. J. Lu, J. Chen, A. M. Klibanov, Pharm. Res. 2005, 22, 373-380.
52. a) S. J. Haggarty, Curr. Opin. Chem. Biol. 2005, 9, 296-303;
53. b) C. M. Dobson, Nature 2004, 432, 824-828.
54. F. Hollfelder, A. J. Kirby, D. S. Tawfik, J. Am. Chem. Soc. 1997, 119, 9578-9579.
55. F. Hollfelder, A. J. Kirby, D. S. Tawfik, J. Org. Chem. 2001, 66, 5866-5874.
56. F. Avenier, J. B. Domingos, L. D. van Vliet, F. Hollfelder, J. Am. Chem. Soc. 2007, 129, 7611-7619.
57. a) J. Suh, Synlett 2001, 1343-1363;
58. b) L. Liu, R. Breslow, J. Am. Chem. Soc. 2002, 124, 4978-4979;
59. c) L. Liu, W. Zhou, J. Chruma, R. Breslow, J. Am. Chem. Soc. 2004, 126, 8136-8137;
60. d) I. Klotz in Enzyme Mechanisms (Eds.: M. I. Page, A. Williams), Royal Society of Chemistry, London, 1987, pp. 14-34;
61. e) I. M. Klotz, J. Suh in Artificial Enzymes (Ed.: R. Breslow), Wiley-Vch, Weinheim, 2005, pp. 63-88.
62. Figure S9 in the Supporting Information shows a comparison between the percentage of cells that express EGFP and total fluorescence intensity (used frequently in other studies). These parameters are linearly related for the set of conditions used in this study.
63. I. Nicoletti, J. Immunol. Methods 1991, 139, 271-279.
64. B. F. Cain, B. C. Baguley, W. A. Denny, J. Med. Chem. 1978, 21, 658-668.
65. a) S. Fergus, A. Bender, D. R. Spring, Curr. Opin. Chem. Biol. 2005, 9, 304-309;
66. b) J. J. Perez, Chem. Soc. Rev. 2005, 34, 143-152.
67. [30] However, the DNA at the concentration used in this study does not transfect significantly.
68. P. C. Bell, M. Bergsma, I. P. Dolbnya, W. Bras, M. C. Stuart, A. E. Rowan, M. C. Feiters, J. B. Engberts, J. Am. Chem. Soc. 2003, 125, 1551-1558.
69. R. Smolarczyk, T. Cichon, A. Sochanik, S. Szala, Cytokine 2005, 29, 283-287.
70. C. McGregor, C. Perrin, M. Monck, P. Camilleri, A. J. Kirby, J. Am. Chem. Soc. 2001, 123, 6215-6220.
71. M. Thomas, A. M. Klibanov, Proc. Natl. Acad. Sci. USA 2003, 100, 9138-9143.
72. S. M. Moghimi, P. Symonds, J. C. Murray, A. C. Hunter, G. Debska, A. Szewczyk, Mol. Ther. 2005, 11, 990-995.
73. N. D. Sonawane, F. C. Szoka, Jr., A. S. Verkman, J. Biol. Chem. 2003, 278, 44826-44831.
74. A. Akinc, M. Thomas, A. M. Klibanov, R. Langer, J. Gene Med. 2005, 7, 657-663.
75. a) C. M. Varga, N. C. Tedford, M. Thomas, A. M. Klibanov, L. G. Griffith, D. A. Lauffenburger, Gene Ther. 2005, 12, 1023-1032;
76. b) D. H. Wakefield, J. J. Klein, J. A. Wolff, D. B. Rozema, Bioconjugate Chem. 2005, 16, 1204-1208.
77. H. Tian, W. Xiong, J. Wei, Y. Wang, X. Chen, X. Jing, Q. Zhu, Biomaterials 2007, 28, 2899-2907.
78. a) C. L. Gebhart, A. V. Kabanov, J. Controlled Release 2001, 73, 401-416;
79. b)W. T. Godbey, A. G. Mikos, J. Controlled Release 2001, 72, 115-125;
80. c) L. Poulain, C. Ziller, C. D. Muller, P. Erbacher, T. Bettinger, J. F. Rodier, J. P. Behr, Cancer Gene Ther. 2000, 7, 644-652;
81. d) Q. R. Chen, L. Zhang, P. W. Luther, A. J. Mixson, Nucleic Acids Res. 2002, 30, 1338-1345;
82. e) M. L. Read, S. Singh, Z. Ahmed, M. Stevenson, S. S. Briggs, D. Oupicky, L. B. Barrett, R. Spice, M. Kendall, M. Berry, J. A. Preece, A. Logan, L. W. Seymour, Nucleic Acids Res. 2005, 33, e86;
83. f) J. P. Clamme, G. Krishnamoorthy, Y. Mely, Biochim. Biophys. Acta Biomembr. 2003, 1617, 52-61;
84. g) W. Dong, S. Li, G. Jin, Q. Sun, D. Ma, Z. Hua, Int. J. Mol. Sci. 2007, 8, 81-102.
85. Propidium iodide stained cells that have survived a washing step could have internal damage that leads to a "long-term" (overnight) effect of a particular compound that has entered the cell. This common toxicity measure merely describes the amount of damage to cells that die as the transfection reagents enter the cell. After overnight incubation these cells are no longer viable, and would be washed away. To account for this, we measured the total count of cells per unit per well.